Literature DB >> 23746523

Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.

Elisa Fadda1.   

Abstract

XPA is an essential protein in the nucleotide excision repair (NER) pathway, in charge of recruiting the ERCC1-XPF endonuclease complex to the DNA damage site. The only currently available structural insight into the binding of XPA to ERCC1 derives from the solution NMR structure of a complex between the ERCC1 central fragment and a 14-residue peptide, corresponding to the highly conserved binding motif of the XPA N-terminus, XPA₆₇₋₈₀. The extensive all-atom molecular-dynamics simulation study of the XPA₆₇₋₈₀ peptide both bound to the ERCC1 central fragment and free in solution presented here completes the profile of the structural determinants responsible for the ERCC1/XPA₆₇₋₈₀ complex stability. In addition to the wild-type, this study also looks at specific XPA₆₇₋₈₀ mutants in complex with the ERCC1 central domain and thus contributes to defining the conformational determinants for binding, as well as all of the essential structural elements necessary for the rational design of an XPA-based, ERCC1-specific inhibitor.
Copyright © 2013 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23746523      PMCID: PMC3672865          DOI: 10.1016/j.bpj.2013.04.023

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  28 in total

1.  The effect of motional averaging on the calculation of NMR-derived structural properties.

Authors:  X Daura; I Antes; W F van Gunsteren; W Thiel; A E Mark
Journal:  Proteins       Date:  1999-09-01

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

3.  XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.

Authors:  Yili Wu; Natalie J Zacal; Andrew J Rainbow; Xu-Dong Zhu
Journal:  DNA Repair (Amst)       Date:  2006-10-18

4.  The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.

Authors:  Barbara Orelli; T Brooke McClendon; Oleg V Tsodikov; Tom Ellenberger; Laura J Niedernhofer; Orlando D Schärer
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

Review 5.  Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

Authors:  E Reed
Journal:  Cancer Treat Rev       Date:  1998-10       Impact factor: 12.111

6.  Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.

Authors:  Sanjeevani Arora; Anbarasi Kothandapani; Kristin Tillison; Vivian Kalman-Maltese; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2010-04-24

7.  On the Role of Water Models in Quantifying the Binding Free Energy of Highly Conserved Water Molecules in Proteins: The Case of Concanavalin A.

Authors:  Elisa Fadda; Robert J Woods
Journal:  J Chem Theory Comput       Date:  2011-09-01       Impact factor: 6.006

Review 8.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

9.  Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations.

Authors:  In Suk Joung; Thomas E Cheatham
Journal:  J Phys Chem B       Date:  2008-07-02       Impact factor: 2.991

Review 10.  DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.

Authors:  Ewan M McNeil; David W Melton
Journal:  Nucleic Acids Res       Date:  2012-08-31       Impact factor: 16.971

View more
  4 in total

Review 1.  Targeting DNA repair and replication stress in the treatment of ovarian cancer.

Authors:  Junko Murai
Journal:  Int J Clin Oncol       Date:  2017-06-22       Impact factor: 3.402

Review 2.  Role of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assembly.

Authors:  Elisa Fadda
Journal:  Comput Struct Biotechnol J       Date:  2015-12-08       Impact factor: 7.271

3.  Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells.

Authors:  Yuanyuan Luo; Tinghe Yu; Xinya Li; Guanhua Qian
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-30       Impact factor: 2.629

4.  Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.

Authors:  Sandra Kohlhase; Natalia V Bogdanova; Peter Schürmann; Marina Bermisheva; Elza Khusnutdinova; Natalia Antonenkova; Tjoung-Won Park-Simon; Peter Hillemanns; Andreas Meyer; Hans Christiansen; Detlev Schindler; Thilo Dörk
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.